Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Current Leases (2016 - 2025)

Historic Current Leases for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to $1.3 million.

  • Adma Biologics' Current Leases rose 880.13% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 880.13%. This contributed to the annual value of $1.2 million for FY2024, which is 1655.5% up from last year.
  • Adma Biologics' Current Leases amounted to $1.3 million in Q3 2025, which was up 880.13% from $1.1 million recorded in Q2 2025.
  • Adma Biologics' Current Leases' 5-year high stood at $1.3 million during Q3 2025, with a 5-year trough of $317910.0 in Q1 2021.
  • Over the past 5 years, Adma Biologics' median Current Leases value was $979536.0 (recorded in 2023), while the average stood at $888314.8.
  • In the last 5 years, Adma Biologics' Current Leases soared by 10571.95% in 2022 and then crashed by 131.35% in 2025.
  • Adma Biologics' Current Leases (Quarter) stood at $591084.0 in 2021, then skyrocketed by 53.11% to $905000.0 in 2022, then rose by 15.47% to $1.0 million in 2023, then grew by 16.56% to $1.2 million in 2024, then rose by 6.57% to $1.3 million in 2025.
  • Its Current Leases stands at $1.3 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.2 million for Q1 2025.